The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Synergy, antagonism, and what the chequerboard puts between them
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Lewis, R. E. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.345 · Cited by 226
Strategic design and three-dimensional analysis of antiviral drug combinations
Prichard, M. N., Prichard, L. E., & Shipman, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.540 · Cited by 106
Cited by
Hyldgaard, M., Mygind, T., & Meyer, R. L. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00012 · Cited by 2,191
Antimicrobial Activity of Some Essential Oils—Present Status and Future Perspectives
Chouhan, S., Sharma, K., & Guleria, S. (2017) · Medicines · doi:10.3390/medicines4030058 · Cited by 1,562
A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
Zorofchian Moghadamtousi, S., Abdul Kadir, H., Hassandarvish, P., Tajik, H., Abubakar, S., & Zandi, K. (2014) · BioMed Research International · doi:10.1155/2014/186864 · Cited by 1,251
Synergism between natural products and antibiotics against infectious diseases
Hemaiswarya, S., Kruthiventi, A. K., & Doble, M. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.06.008 · Cited by 916
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 881
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1845pp · Cited by 738
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Di Veroli, G. Y., Fornari, C., Wang, D., Mollard, S., Bramhall, J. L., Richards, F. M., & Jodrell, D. I. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw230 · Cited by 736
Combination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Vaou, N., Stavropoulou, E., Voidarou, C. (., Tsakris, Z., Rozos, G., Tsigalou, C., & Bezirtzoglou, E. (2022) · Antibiotics · doi:10.3390/antibiotics11081014 · Cited by 406
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Bellmann, R., & Smuszkiewicz, P. (2017) · Infection · doi:10.1007/s15010-017-1042-z · Cited by 389
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane
Sabnis, A., Hagart, K. L., Klöckner, A., Becce, M., Evans, L. E., Furniss, R. C. D., Mavridou, D. A., Murphy, R., Stevens, M. M., Davies, J. C., et al. (2021) · eLife · doi:10.7554/elife.65836 · Cited by 389
van Vuuren, S., & Viljoen, A. (2011) · Planta Medica · doi:10.1055/s-0030-1250736 · Cited by 367
Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria
Palaniappan, K., & Holley, R. A. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.04.001 · Cited by 353
Stokes, J. M., MacNair, C. R., Ilyas, B., French, S., Côté, J.-P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.28 · Cited by 340
Singh, N., Limaye, A. P., Forrest, G., Safdar, N., Mu??oz, P., Pursell, K., Houston, S., Rosso, F., Montoya, J. G., Patton, P., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000202421.94822.f7 · Cited by 336
Hollmann, A., Martinez, M., Maturana, P., Semorile, L. C., & Maffia, P. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00204 · Cited by 334
Meletiadis, J., Pournaras, S., Roilides, E., & Walsh, T. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-09 · Cited by 325
Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle
Zore, G. B., Thakre, A. D., Jadhav, S., & Karuppayil, S. M. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.03.008 · Cited by 319
Antimicrobial activity of limonene enantiomers and 1,8‐cineole alone and in combination
Vuuren, S. F. V., & Viljoen, A. M. (2007) · Flavour and Fragrance Journal · doi:10.1002/ffj.1843 · Cited by 313
Combination Treatment of Invasive Fungal Infections
Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., & Ghannoum, M. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.163-194.2005 · Cited by 308
Vazquez-Muñoz, R., Meza-Villezcas, A., Fournier, P. G. J., Soria-Castro, E., Juarez-Moreno, K., Gallego-Hernández, A. L., Bogdanchikova, N., Vazquez-Duhalt, R., & Huerta-Saquero, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224904 · Cited by 307
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Schiessl, K. T., Hu, F., Jo, J., Nazia, S. Z., Wang, B., Price-Whelan, A., Min, W., & Dietrich, L. E. P. (2019) · Nature Communications · doi:10.1038/s41467-019-08733-w · Cited by 258
Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens
Saxena, D., Maitra, R., Bormon, R., Czekanska, M., Meiers, J., Titz, A., Verma, S., & Chopra, S. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00016-1 · Cited by 217
“In the fi eld of synergy, a fractional inhibitory concentration index (FICI) below 0.5 is considered as a benchmark for the synergistic activity 67 .”
InfluentialSynergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen
Ramón-García, S., Ng, C., Anderson, H., Chao, J. D., Zheng, X., Pfeifer, T., Av-Gay, Y., Roberge, M., & Thompson, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00474-11 · Cited by 185
Cross‐species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Spitzer, M., Griffiths, E., Blakely, K. M., Wildenhain, J., Ejim, L., Rossi, L., De Pascale, G., Curak, J., Brown, E., Tyers, M., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.31 · Cited by 183
Fortwendel, J. R., Juvvadi, P. R., Pinchai, N., Perfect, B. Z., Alspaugh, J. A., Perfect, J. R., & Steinbach, W. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01154-08 · Cited by 161
“The synergistic relationship between the two cell wall inhibitors during cotreatment was calculated using the fractional inhibitory concentration index (FICI), with synergy defined as an FICI of 0.5 ( 21 ).”
MethodInfluentialSystems-level antimicrobial drug and drug synergy discovery
Roemer, T., & Boone, C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1205 · Cited by 159
Current status of antifungal susceptibility testing methods
Arikan, S. (2007) · Medical Mycology · doi:10.1080/13693780701436794 · Cited by 152
Heat Shock Protein 90 Is Required for Conidiation and Cell Wall Integrity in Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., Fortwendel, J. R., & Steinbach, W. J. (2012) · Eukaryotic Cell · doi:10.1128/ec.00032-12 · Cited by 136
Xu, Y., Wang, Y., Yan, L., Liang, R.-M., Dai, B.-D., Tang, R.-J., Gao, P.-H., & Jiang, Y.-Y. (2009) · Journal of Proteome Research · doi:10.1021/pr9005074 · Cited by 113
Fiori, A., & Van Dijck, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06017-11 · Cited by 112
Holmes, A. R., Keniya, M. V., Ivnitski-Steele, I., Monk, B. C., Lamping, E., Sklar, L. A., & Cannon, R. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05706-11 · Cited by 106
“In accordance with published guidelines (35), an FICI of 0.”
MethodLamping, E., Ranchod, A., Nakamura, K., Tyndall, J. D. A., Niimi, K., Holmes, A. R., Niimi, M., & Cannon, R. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01095-08 · Cited by 100
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans
Liu, S., Yue, L., Gu, W., Li, X., Zhang, L., & Sun, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150859 · Cited by 87
Lamoth, F., Juvvadi, P. R., Gehrke, C., & Steinbach, W. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01857-12 · Cited by 88
Scorzoni, L., Sangalli-Leite, F., de Lacorte Singulani, J., de Paula e Silva, A. C. A., Costa-Orlandi, C. B., Fusco-Almeida, A. M., & Mendes-Giannini, M. J. S. (2016) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2016.02.005 · Cited by 82
De Cremer, K., Lanckacker, E., Cools, T. L., Bax, M., De Brucker, K., Cos, P., Cammue, B. P. A., & Thevissen, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04229-14 · Cited by 77
Gu, W., Guo, D., Zhang, L., Xu, D., & Sun, S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03046-15 · Cited by 80
Campos, A. I., & Zampieri, M. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.001 · Cited by 79
Robbins, N., Spitzer, M., Yu, T., Cerone, R. P., Averette, A. K., Bahn, Y.-S., Heitman, J., Sheppard, D. C., Tyers, M., & Wright, G. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.018 · Cited by 78
Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans
Gamarra, S., Rocha, E. M. F., Zhang, Y.-Q., Park, S., Rao, R., & Perlin, D. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01728-09 · Cited by 70
Kim, J. H., Cheng, L. W., Chan, K. L., Tam, C. C., Mahoney, N., Friedman, M., Shilman, M. M., & Land, K. M. (2020) · Antibiotics · doi:10.3390/antibiotics9110812 · Cited by 71
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
Long, T. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00898-17 · Cited by 67
“5, a metric used to define synergism (12).”
BackgroundSun, L.-M., Liao, K., Liang, S., Yu, P.-H., & Wang, D.-Y. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12737 · Cited by 67
Cordeiro, R. D. A., Evangelista, A. J. D. J., Serpa, R., Marques, F. J. D. F., Melo, C. V. S. D., Oliveira, J. S. D., Franco, J. D. S., Alencar, L. P. D., Bandeira, T. D. J. P. G., Brilhante, R. S. N., et al. (2016) · Microbiology · doi:10.1099/mic.0.000222 · Cited by 63
Zhu, C., Liao, B., Ye, X., Zhou, Y., Chen, X., Liao, M., Cheng, L., Zhou, X., & Ren, B. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106394 · Cited by 60
Ning, Y., Ling, J., & Wu, C. D. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.07.001 · Cited by 56
Savage, K. A., Parquet, M. D. C., Allan, D. S., Davidson, R. J., Holbein, B. E., Lilly, E. A., & Fidel, P. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02576-17 · Cited by 53
Rossi, S. A., de Oliveira, H. C., Agreda-Mellon, D., Lucio, J., Mendes-Giannini, M. J. S., García-Cambero, J. P., & Zaragoza, O. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01921-19 · Cited by 48
Lamoth, F., Alexander, B. D., Juvvadi, P. R., & Steinbach, W. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku549 · Cited by 47
Patil, S. D., Sharma, R., Srivastava, S., Navani, N. K., & Pathania, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057370 · Cited by 45
Antifungal combinations in Mucorales: A microbiological perspective
Schwarz, P., Cornely, O. A., & Dannaoui, E. (2019) · Mycoses · doi:10.1111/myc.12909 · Cited by 43
Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans
Li, D.-D., Chai, D., Huang, X.-W., Guan, S.-X., Du, J., Zhang, H.-Y., Sun, Y., & Jiang, Y.-Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-17 · Cited by 42
“5 but 4 was considered indifferent (33).”
Jin, J., Guo, N., Zhang, J., Ding, Y., Tang, X., Liang, J., Li, L., Deng, X., & Yu, L. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02900.x · Cited by 40
Seyedmousavi, S., Meletiadis, J., Melchers, W. J. G., Rijs, A. J. M. M., Mouton, J. W., & Verweij, P. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00980-12 · Cited by 38
“5 to 4 (21, 47, 48) indicated synergism for 61.”
De Cremer, K., De Brucker, K., Staes, I., Peeters, A., Van den Driessche, F., Coenye, T., Cammue, B. P. A., & Thevissen, K. (2016) · Scientific Reports · doi:10.1038/srep27463 · Cited by 34
In vitro antimycotic activity of a Williopsis saturnus killer protein against food spoilage yeasts
Goretti, M., Turchetti, B., Buratta, M., Branda, E., Corazzi, L., Vaughan-Martini, A., & Buzzini, P. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.02.013 · Cited by 35
The synergistic antifungal activity of resveratrol with azoles against Candida albicans
Wang, J., Zhang, X., Gao, L., Wang, L., Song, F., Zhang, L., & Wan, Y. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13458 · Cited by 29
Saputo, S., Faustoferri, R. C., & Quivey, R. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-17 · Cited by 29
Foletto, V. S., Serafin, M. B., Bottega, A., da Rosa, T. F., Machado, C. D. S., Coelho, S. S., & Hörner, R. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02507-6 · Cited by 27
“…of the interaction, that is, of the synergism between the drugs and ciprofloxacin, the sum of the FICI was calculated, whose interpretation was classified as “synergistic” (FIC ≤ 0.5), “no interaction” (FIC > 0.5 and ≤ 4.0), and “antagonistic” (FIC > 4.0) (Konaté et al. 2012; Odds 2003).”
BackgroundInfluentialIn vitro synergism of simvastatin and fluconazole against Candida species
Menezes, E. A., Vasconcelos Júnior, A. A. D., Silva, C. L. F., Plutarco, F. X., Cunha, M. D. C. D. S. O., & Cunha, F. A. (2012) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652012000400003 · Cited by 25
Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole
Li, L. P., Liu, W., Liu, H., Zhu, F., Zhang, D. Z., Shen, H., Xu, Z., Qi, Y. P., Zhang, S. Q., Chen, S. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126393 · Cited by 17
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris
Li, J., Coste, A. T., Bachmann, D., Sanglard, D., & Lamoth, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01395-21 · Cited by 14
“Drug interactions between NSC319726 and fluconazole, amphotericin B, and micafungin were tested by checkerboard dilution to determine the FICI, as described previously (14).”
MethodGhasemian Yadegari, J., Khudair Khalaf, A., Ezzatkhah, F., Shakibaie, M., Mohammadi, H. R., & Mahmoudvand, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114984 · Cited by 12
Bakadlag, R., Limniatis, G., Georges, G., & Georges, E. (2023) · BMC Cancer · doi:10.1186/s12885-022-10474-x · Cited by 9
Ripley, D. A., Morris, R. H., & Maddocks, S. E. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12553 · Cited by 8
“5 to ≤ 4 – additivity and > 4 – antagonism (Odds, 2003; Sopirala et al., 2010).”
MethodInfluentialde Souza, A. Á., Lima, A. M., dede Oliveira BezerraSousa, D., Nogueira, F. C., do Sacramento Neto, J. C., Dias, L. P., Araújo, N. M. S., Nagano, C. S., Júnior, H. V. N., da Silva, C. R., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09979-5 · Cited by 8
Brilhante, R. S. N., Fonseca, X. M. Q. C., Pereira, V. S., Araújo, G. D. S., Oliveira, J. S. D., Garcia, L. G. S., Rodrigues, A. M., Camargo, Z. P. D., Pereira-Neto, W. A., Castelo-Branco, D. D. S. C. M., et al. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001195 · Cited by 5
Metadata
- Authors
- Odds, F. C.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-12
- Volume
- 52
- Issue
- 1
- Pages
- 1-1
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2016562927
- Cited by
- 2,481
- References
- 4
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.